119
Views
19
CrossRef citations to date
0
Altmetric
Case Report

Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases

, , , , , , , , , , , & show all
Pages 190-194 | Received 17 Jan 2012, Accepted 12 Mar 2012, Published online: 02 Jan 2014

References

  • Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22:639–43.
  • Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571–6.
  • Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-asso-ciated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progres-sive interstitial lung disease. Arthritis Rheum. 2009;63:2193–200.
  • Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermato-myopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626–36.
  • Lakhanpal H, Lie JT, Conn DL, Martin WJ 2nd. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis. 1987;46: 23–9.
  • Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri S, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with dermatomyositis. Rheumatology (Oxford). 2012; in press.
  • Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol. 1993;100:124S–7S.
  • Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol. 2009; 28:979–84.
  • Mukae H, Ishimoto H, Sakamoto N, Hara S, Kalcugawa T, Nakayama S, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest. 2009;136:1341–7.
  • Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, et al. Interstitial lung diseases associated with amyopathic der-matomyositis. Eur Respir J. 2006;28:1005–12.
  • Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyo-sitis and related conditions (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2007;30:444–54.
  • Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-asso-ciated interstitial lung disease as a complication of dermatomy-ositis. Rheumatology (Oxford). 2010;49:1713–9.
  • Sato S. Autoantibodies specifically detected in patients with polymyositis/dermatomyositis. Nihon Rinsho Meneki Gakkai Kaishi. 2006;29:85–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.